Skip to Main Content

Author Details

Nobuko Hamasaki-Katagiri
Center for Biologics Evaluation & Research
1985
46
18
PMIDPaper TitleJournal TitlePublished Year
36052345Protocol to identify host-viral protein interactions between coagulation-related proteins and their genetic variants with SARS-CoV-2 proteins.STAR Protoc2022
35413099Structural, functional, and immunogenicity implications of F9 gene recoding.Blood Adv2022
35667091Synonymous ADAMTS13 variants impact molecular characteristics and contribute to variability in active protein abundance.Blood Adv2022
36052345Protocol to identify host-viral protein interactions between coagulation-related proteins and their genetic variants with SARS-CoV-2 proteins.STAR Protoc2022
35667091Synonymous ADAMTS13 variants impact molecular characteristics and contribute to variability in active protein abundance.Blood Adv2022
35413099Structural, functional, and immunogenicity implications of F9 gene recoding.Blood Adv2022
34256028New approaches to predict the effect of co-occurring variants on protein characteristics.Am J Hum Genet2021
33730015Gene variants of coagulation related proteins that interact with SARS-CoV-2.PLoS Comput Biol2021
34256028New approaches to predict the effect of co-occurring variants on protein characteristics.Am J Hum Genet2021
33730015Gene variants of coagulation related proteins that interact with SARS-CoV-2.PLoS Comput Biol2021
32531546In silico features of ADAMTS13 contributing to plasmatic ADAMTS13 levels in neonates with congenital heart disease.Thromb Res2020
31982380TissueCoCoPUTs: Novel Human Tissue-Specific Codon and Codon-Pair Usage Tables Based on Differential Tissue Gene Expression.J Mol Biol2020
32935103Potential impact on coagulopathy of gene variants of coagulation related proteins that interact with SARS-CoV-2.bioRxiv2020
32531546In silico features of ADAMTS13 contributing to plasmatic ADAMTS13 levels in neonates with congenital heart disease.Thromb Res2020
32973171Sequence analysis of SARS-CoV-2 genome reveals features important for vaccine design.Sci Rep2020
32511300Sequence analysis of SARS-CoV-2 genome reveals features important for vaccine design.bioRxiv2020
31982380TissueCoCoPUTs: Novel Human Tissue-Specific Codon and Codon-Pair Usage Tables Based on Differential Tissue Gene Expression.J Mol Biol2020
32973171Sequence analysis of SARS-CoV-2 genome reveals features important for vaccine design.Sci Rep2020
32935103Potential impact on coagulopathy of gene variants of coagulation related proteins that interact with SARS-CoV-2.bioRxiv2020
32511300Sequence analysis of SARS-CoV-2 genome reveals features important for vaccine design.bioRxiv2020
31029701Codon and Codon-Pair Usage Tables (CoCoPUTs): Facilitating Genetic Variation Analyses and Recombinant Gene Design.J Mol Biol2019
31731663A Single Synonymous Variant (c.354G&gt;A [p.P118P]) in <i>ADAMTS13</i> Confers Enhanced Specific Activity.Int J Mol Sci2019
31664102Effects of codon optimization on coagulation factor IX translation and structure: Implications for protein and gene therapies.Sci Rep2019
31029701Codon and Codon-Pair Usage Tables (CoCoPUTs): Facilitating Genetic Variation Analyses and Recombinant Gene Design.J Mol Biol2019
31257730Splicing dysregulation contributes to the pathogenicity of several F9 exonic point variants.Mol Genet Genomic Med2019
31731663A Single Synonymous Variant (c.354G&gt;A [p.P118P]) in <i>ADAMTS13</i> Confers Enhanced Specific Activity.Int J Mol Sci2019
31664102Effects of codon optimization on coagulation factor IX translation and structure: Implications for protein and gene therapies.Sci Rep2019
31257730Splicing dysregulation contributes to the pathogenicity of several F9 exonic point variants.Mol Genet Genomic Med2019
28007939Single synonymous mutation in factor IX alters protein properties and underlies haemophilia B.J Med Genet2017
28866379Compounding variants rescue the effect of a deleterious ADAMTS13 mutation in a child with severe congenital heart disease.Thromb Res2017
28007939Single synonymous mutation in factor IX alters protein properties and underlies haemophilia B.J Med Genet2017
27933712The importance of mRNA structure in determining the pathogenicity of synonymous and non-synonymous mutations in haemophilia.Haemophilia2017
28232867Recent advances in (therapeutic protein) drug development.F1000Res2017
28232867Recent advances in (therapeutic protein) drug development.F1000Res2017
28866379Compounding variants rescue the effect of a deleterious ADAMTS13 mutation in a child with severe congenital heart disease.Thromb Res2017
27933712The importance of mRNA structure in determining the pathogenicity of synonymous and non-synonymous mutations in haemophilia.Haemophilia2017
25470321Genetic determinants of immunogenicity to factor IX during the treatment of haemophilia B.Haemophilia2015
25470321Genetic determinants of immunogenicity to factor IX during the treatment of haemophilia B.Haemophilia2015
24417758Factor IX oligomerization underlies reduced activity upon disruption of physiological conditions.Haemophilia2014
25483793Three-dimensional reconstruction of the axon extending from the dermal photoreceptor cell in the extraocular photoreception system of a marine gastropod, onchidium.Zoolog Sci2014
24417758Factor IX oligomerization underlies reduced activity upon disruption of physiological conditions.Haemophilia2014
25483793Three-dimensional reconstruction of the axon extending from the dermal photoreceptor cell in the extraocular photoreception system of a marine gastropod, onchidium.Zoolog Sci2014
23346910Multiple in silico tools predict phenotypic manifestations in congenital thrombotic thrombocytopenic purpura.Br J Haematol2013
23901115Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma.Proc Natl Acad Sci U S A2013
24060103Building better drugs: developing and regulating engineered therapeutic proteins.Trends Pharmacol Sci2013
23920358A gene-specific method for predicting hemophilia-causing point mutations.J Mol Biol2013
23346910Multiple in silico tools predict phenotypic manifestations in congenital thrombotic thrombocytopenic purpura.Br J Haematol2013
24060103Building better drugs: developing and regulating engineered therapeutic proteins.Trends Pharmacol Sci2013
23901115Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma.Proc Natl Acad Sci U S A2013
23920358A gene-specific method for predicting hemophilia-causing point mutations.J Mol Biol2013
  • 1 - 50 of 92

Recommended Authors

??ke V??stermark
Uppsala University
Career Start Year 2004
Number of shared co-authors 0
Hamid R Kalhor
Sharif University of Technology
Career Start Year 1998
Number of shared co-authors 0
Andrew P May
Fluidigm Corporation
Career Start Year 1997
Number of shared co-authors 0
Ping Liang
College of Chemistry and Chemical Engineering, Hunan University
Career Start Year 1995
Number of shared co-authors 0
Nicholas E Sherman
University of Virginia
Career Start Year 1994
Number of shared co-authors 0
Bianca Habermann
Aix Marseille University, CNRS, Turing Center for Living Systems
Career Start Year 1993
Number of shared co-authors 0
Gyorgy Babnigg
Argonne National Laboratory
Career Start Year 1992
Number of shared co-authors 0
Jes??s Vald??s
Center for Research and Advanced Studies of the IPN, National Polytechnic Institute
Career Start Year 1990
Number of shared co-authors 0
Subbiah Parthasarathy
New York University Grossman School of Medicine
Career Start Year 1990
Number of shared co-authors 0
Yoav Peleg
Weizmann Institute of Science
Career Start Year 1990
Number of shared co-authors 0
Andreas Hofmann
Heidelberg University
Career Start Year 1989
Number of shared co-authors 0
Chris P Ponting
The University of Edinburgh
Career Start Year 1989
Number of shared co-authors 5
Muh-Ching Yee
Stanford University
Career Start Year 1988
Number of shared co-authors 0
Denis C Shields
Conway Institute of Biomolecular and Biomedical Research, University College Dublin
Career Start Year 1987
Number of shared co-authors 1
Michal Linial
Institute of Life Sciences, The Hebrew University of Jerusalem
Career Start Year 1986
Number of shared co-authors 0
Aled M Edwards
University of Toronto
Career Start Year 1984
Number of shared co-authors 0
Hediye Erdjument-Bromage
Neuroscience Institute, NYU Grossman School of Medicine
Career Start Year 1984
Number of shared co-authors 0
Tamar Unger
Weizmann Institute of Science
Career Start Year 1983
Number of shared co-authors 0
Enrique Querol
Institut de Biotecnologia i Biomedicina, Universitat Autonoma de Barcelona
Career Start Year 1980
Number of shared co-authors 0
Hans J Vogel
University of Calgary
Career Start Year 1979
Number of shared co-authors 0
Shigeyuki Yokoyama
Shinshu University School of Medicine
Career Start Year 1979
Number of shared co-authors 0
William H Eschenfeldt
Midwest Center for Structural Genomics, Argonne National Laboratory
Career Start Year 1975
Number of shared co-authors 0
J C Venter
The J. Craig Venter Institute
Career Start Year 1972
Number of shared co-authors 3
Jack E Dixon
University of California
Career Start Year 1972
Number of shared co-authors 0
David L Nelson
Baylor College of Medicine
Career Start Year 1968
Number of shared co-authors 1
Sung-Hou Kim
University of California berkeley
Career Start Year 1967
Number of shared co-authors 0
Robert M Stroud
University of California San Francisco
Career Start Year 1965
Number of shared co-authors 0
Young-Ki Paik
College of Life Sciences and Biotechnology, Yonsei University
Career Start Year 1962
Number of shared co-authors 0
David Schlessinger
NIH/National Institute of Ageing
Career Start Year 1960
Number of shared co-authors 2
John R Yates
TheScripps Research Institute
Career Start Year 1960
Number of shared co-authors 0

Collaborators

Chava Kimchi-Sarfaty
Center for Biologics Evaluation and Research
Co-authored papers 26
Anton A Komar
Center for Gene Regulation in Health and Disease, Cleveland State University
Co-authored papers 16
Vijaya L Simhadri
Center for Biologics Evaluation and Research
Co-authored papers 7
Michael DiCuccio
National Center for Biotechnology Information, National Institutes of Health
Co-authored papers 6
Juan C Ibla
Boston Children's Hospital
Co-authored papers 5
Sujata Jha
Feinberg School of Medicine, Northwestern University
Co-authored papers 2
Steven A Rosenberg
University of Colorado School of Medicine
Co-authored papers 1
Hannah Carter
University of California San Diego
Co-authored papers 1
Stephen C J Parker
University of Michigan ann arbor
Co-authored papers 1
Xiaomu Wei
Cornell University
Co-authored papers 1
Mario A Morken
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 1
Steven E Robinson
University of Colorado Anschutz Medical Campus
Co-authored papers 1
William A Robinson
National Centre for Asbestos Related Diseases, University of Western Australia
Co-authored papers 1
Yardena Samuels
Weizmann Institute of Science
Co-authored papers 1
Jared J Gartner
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Umesh Bhanot
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Francis S Collins
University of Michigan ann arbor
Co-authored papers 1
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 1
Elliott H Margulies
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 1
Laura Elnitski
National Human Genome Research Institute
Co-authored papers 1
Michael L Stitzel
Institute for Systems Genomics
Co-authored papers 1
Todd D Prickett
National Cancer Institute
Co-authored papers 1
Valer Gotea
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 1
Alexey Golikov
Co-authored papers 1
Rachel Karchin
Johns Hopkins University
Co-authored papers 1
Susan R Davis
Co-authored papers 1
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
Guo Chen
China Pharmaceutical University
Co-authored papers 1
Ken Dutton-Regester
QIMR Berghofer Medical Research Institute
Co-authored papers 1
Giovanni Parmigiani
Dana Farber Cancer Institute.
Co-authored papers 1
Release 1.2